Circassia Pharmaceuticals PLC (GB:NIOX)
LSE:NIOX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 48.70M | £ 41.80M | £ 36.80M | £ 31.30M | £ 27.90M |
| Gross Profit | £ 29.60M | £ 30.20M | £ 26.50M | £ 22.20M | £ 19.00M |
| Operating Income | £ 10.70M | £ 7.70M | £ 4.60M | £ 1.80M | £ -4.30M |
| EBITDA | £ 10.70M | £ 12.20M | £ 8.60M | £ 15.20M | £ 3.10M |
| Net Income | £ 7.00M | £ 3.70M | £ 10.70M | £ 16.10M | £ 3.60M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 19.90M | £ 10.90M | £ 19.90M | £ 19.40M | £ 12.60M |
| Total Assets | £ 76.20M | £ 68.40M | £ 91.50M | £ 98.50M | £ 86.40M |
| Total Debt | £ 1.00M | £ 1.50M | £ 1.10M | £ 1.00M | £ 1.30M |
| Net Debt | £ -18.90M | £ -9.40M | £ -18.80M | £ -18.40M | £ -11.30M |
| Total Liabilities | £ 8.60M | £ 8.90M | £ 7.70M | £ 16.60M | £ 19.60M |
| Stockholders' Equity | £ 73.70M | £ 59.50M | £ 83.80M | £ 81.90M | £ 66.80M |
| Cash Flow | |||||
| Free Cash Flow | £ 15.60M | £ 16.20M | £ 11.30M | £ 6.60M | £ 1.20M |
| Operating Cash Flow | £ 15.80M | £ 17.20M | £ 11.60M | £ 6.70M | £ 1.40M |
| Investing Cash Flow | £ -1.20M | £ -1.00M | £ -300.00K | £ -100.00K | £ -200.00K |
| Financing Cash Flow | £ -5.50M | £ -25.10M | £ -10.50M | £ -500.00K | £ 4.10M |